Previous 10 | Next 10 |
home / stock / hlukf / hlukf news
The following slide deck was published by H. Lundbeck A/S in conjunction with their 2020 Q2 earnings Read more ...
H. Lundbeck A/S (HLUKF) Q1 2020 Earnings Conference Call May 12, 2020 7:00 AM ET Company Participants Deborah Dunsire - Chief Executive Officer Johan Luthman - Executive Vice President, R&D Anders Gotzsche - Chief Financial Officer Jacob Tolstrup - Executive Vice President,...
The following slide deck was published by H. Lundbeck A/S in conjunction with their 2020 Q1 earnings Read more ...
H. Lundbeck A/S ( OTC:HLUKF ): Q1 Non-GAAP EPS of DKK4.89; GAAP EPS of DKK0.76. More news on: H. Lundbeck A/S, Earnings news and commentary, Healthcare stocks news, Read more ...
Noteworthy events during the week of February 16 - 22 for healthcare investors. More news on: Agile Therapeutics, Inc., Merck & Co., Inc., Cellectar Biosciences, Inc., Healthcare stocks news, , Read more ...
The following slide deck was published by H. Lundbeck A/S in conjunction with their 2019 Q4 earnings Read more ...
The following slide deck was published by H. Lundbeck A/S in conjunction with this Read more ...
Biotech Pulse Biotech finally has a pulse. The improving appetite for risk has resuscitated the moribund biotechs and pharma (biopharma) groups. The Nasdaq Biotech ( IBB ) and the S&P Biotech ( XBI ) indexes have begun their advance from their year-to-date lows recorded earlier in Octo...
H. Lundbeck A/S (HLUKF) Q3 2019 Earnings Conference Call November 5, 2019 07:00 AM ET Company Participants Deborah Dunsire - President & Chief Executive Officer Anders Götzsche - Executive Vice President & Chief Financial Officer Johan Luthman - Head of Research &...
The following slide deck was published by H. Lundbeck A/S in conjunction with their 2019 Q3 earnings Read more ...
News, Short Squeeze, Breakout and More Instantly...
H Lundbeck A/S Company Name:
HLUKF Stock Symbol:
OTCMKTS Market:
COPENHAGEN, Denmark , Aug. 31, 2020 /PRNewswire/ -- H. Lundbeck A/S (Lundbeck) today announced headline results from the parallel group, double-blind, randomized, placebo-controlled RELIEF study [i] that assessed the efficacy and tolerability of Vyepti when initiated during a migrain...
Health Canada Approves Otsuka and Lundbeck's REXULTI® (brexpiprazole) as Adjunctive Treatment of Major Depressive Disorder Canada NewsWire MONTREAL, Feb. 22, 2019 MONTREAL , Feb. 22, 2019 /CNW Telbec/ - Otsuka Pharmaceutical Canada Inc. (Otsuka) and Lundbeck Can...